Business Wire

BAI Announces 2021 Global Innovation Award Finalists

9.11.2021 15:30:00 EET | Business Wire | Press release

Share

BAI announced the finalists for the 11th Annual 2021 BAI Global Innovation Awards, the industry’s prestigious awards program that celebrates new and innovative solutions in the financial services industry worldwide. The 2021 BAI Global Innovation Awards finalists are:

Innovation in Compliance and Risk Management

  • Emirates NBD Bank, United Arab Emirates: Transforming the Anti-Money Laundering Framework
  • Hummingbird, United States: Hummingbird Platform
  • UnionBank of the Philippines, Philippines: Credit Card Fraud Detection Model

Innovation in Consumer Product and Services

  • Commonwealth Bank of Australia, Australia: CommBank Benefits Finder
  • FNB Insurance, South Africa: Future Family Benefit on Critical Illness
  • ICICI Bank, India: IntelliCollect – AI powered Contactless Collection
  • PNC Financial Services Group, United States: Low Cash Mode
  • Yapı Kredi, Turkey: My Car+: Everything about your vehicle

Innovation in Digital Transformation

  • AVIVA POLSKA, Poland: eInsurance Digital Omnichannel Life Insurance Application Journey
  • Bank of America, United States: Bank of America Mobile Banking Super App
  • Deutsche Bank, Germany: Deutsche Bank API Program Embedded Finance Initiative
  • OneConnect Smart Technology Co., LTD, China: Global Markets Digital Lab in Abu Dhabi
  • SolarisBank, Netherlands: Banking as a Service

Innovation in Human Capital

  • KeyBank, United States: Remote Intern Program
  • Payactiv, United States: Livelihood Employee Experience Platform
  • Royal Credit Union, United States: Employee Learning Experience

Innovation in Environmental, Social and Governance (ESG)

  • Bank of Montreal, Canada: BMO Give & Go
  • BMO Harris Bank, United States: BMO for Black and Latinx Businesses
  • Citizens Financial Group, United States: Citizens Green Deposits
  • imagin, Spain: imagin: A Community with a Positive Impact
  • Lufax Holding Ltd., China: Farmers’ Assistance Fund
  • Wintrust Financial Corporation, United States: Wintrust Paycheck Protection Program (PPP) Resource Centers

Innovation in Internal Process

  • Alior Bank, Poland: InfoNina, virtual assistant
  • ICICI Bank, India: Pre-Delinquency Management
  • Israel Discount Bank, Israel: POPCORN - An Innovative Customer Listening Model
  • PKO Bank Polski, Poland: Road to Paperless Banking Empowered by Blockchain Technology
  • PZU SA, South Africa: AI Assistant in Claims (Field Inspection)

Innovation in Small Business Product & Services

  • HSBC UK, United Kingdom: HSBC Kinetic, Mobile Banking Service
  • Lufax Holding Ltd., China: Lufax "Xingyun" Smart Loan Solution
  • Ping An OneConnect Bank Limited, Hong Kong: “PAOB SME" Mobile Application
  • Santander Bank, N.A., United States: Santander Treasury Fusion for Where You Do Business
  • Tribal Credit, United States: Tribal Credit Tools

The winners will be announced in December 2021. To learn more please visit BAI Global Innovation Awards.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Holly Hughes
BAI, Chicago
hhughes@bai.org
+1 (312) 683-2305

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy8.6.2026 09:00:00 EEST | Press release

Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workflow into a single environment. PlanOne™ is FDA 510(k) cleared. "PlanOne™ began with listening. Over the years, our work on control systems in radiation oncology has put us in direct, ongoing contact with medical physicists and clinical teams at some of the leading facilities in the world," said Mark Pleško, CEO of Cosylab. "Our partners have been clear on what matters most for particle therapy: physics accuracy they can defend, clinical confidence at the point of plan approval, and a platform built to grow with AI and adaptive workflows. We designed PlanOne™ around those three priorities, and we'll keep developing it together with the clinical community that helped shape it." Physics-accurate, radiobiologically informed planning PlanOne™ is built on a GPU-accelerated Monte Carlo dose engin

BitGo MENA Launches Regulated Electronic Trading, Delivering Full Suite Trading Services to the Region8.6.2026 07:00:00 EEST | Press release

BitGo MENA FZE (“BitGo MENA”), a subsidiary of BitGo Holdings, Inc. (NYSE: BTGO) (“BitGo”), the digital asset infrastructure company, today announced the launch of electronic trading in the Middle East and North African (MENA). With this launch, clients can now access a comprehensive trading solution combining BitGo MENA’s established over-the-counter (OTC) trading offering with institutional-grade electronic execution, all operating under BitGo MENA’s Broker-Dealer license from Dubai’s Virtual Assets Regulatory Authority (VARA). The launch further expands BitGo MENA’s regulated product suite under VARA’s oversight, marking another step in the region’s continued buildout of institutional digital asset infrastructure amid growing demand for integrated execution and custody solutions. “The Middle East and North Africa has quickly become one of the most exciting regions in the world for digital assets, with regulators, institutions, and innovators moving with real purpose,” said Mike Bels

Vertex Presents New Data on ALYFTREK ® at European Cystic Fibrosis Conference5.6.2026 19:00:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating the long-term safety and efficacy profile of the medicine. The data, presented at the European Cystic Fibrosis Conference, show children ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including those who are homozygous for the F508del mutation (F/F) and those who have F508del/minimal function mutations (F/MF)on ALYFTREK had further improvement in CFTR function from a TRIKAFTA ® baseline as measured by sweat chloride (SwCl), with 65% having achieved SwCl <30 mmol/L after treatment with ALYFTREK. Vertex also presented Phase 3 data of children ages 1 to <2 with TRIKAF

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 14:00:00 EEST | Press release

Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built

DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 13:41:00 EEST | Press release

DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye